Defective macrophage plasticity exacerbates progression of inflammation in patients with rheumatoid arthritis
8 affiliations
- 1School of Biotechnology, Dublin City University
- 2Life Sciences Institute, Dublin City University
- 3Department of Rheumatology, Beaumont Hospital
- 4Royal College of Surgeons in Ireland
- 5Department of Rheumatology, Naas General Hospital
- 6Tallaght University Hospital
- 7Medical Biology and Immunology group, Laboratory of Biology, Medical School, University of Ioannina
- 8Biomedical Sciences Institute, FORTH
Abstract
Background: Rheumatoid arthritis (RA) affects over 1% of the global population. Current therapies cannot cure the disease, and only 20% of patients achieve long-term, drug-free remission. Recent studies highlight a dual role for synovial macrophages, which comprise both proinflammatory and remission-associated subsets. However, how macrophage plasticity and metabolic programming drive RA pathogenesis remains poorly understood. This study investigated how phenotypic and functional shifts in macrophage subsets contribute to chronic joint inflammation and bone erosion.
Methods: Peripheral blood CD14+ monocytes from RA patients and healthy controls (HC) were differentiated into M1, M2a, M2b, M2c, and M2d macrophage subsets. To simulate the inflamed joint, cells were cultured under both atmospheric oxygen and hypoxic conditions. Phenotypic and chemokine receptor profiles were evaluated using RT-qPCR and multiparametric flow cytometry for a panel of markers, including CD14, CD11c, CD38, CD86, CD163, CD206, CD209, MerTK, IRF4, CCR1, CCR2, CCR4, CCR5, and CCR8. Metabolic characterization was performed via flow cytometric assessment of protein synthesis. To validate these phenotypes in vivo , scRNA-seq analysis (GSE200815) was conducted on synovial tissue macrophages from RA and HC individuals. Finally, the functional capacity of each macrophage subtype to differentiate into bone-resorbing osteoclasts was assessed.
Results: scRNA-seq data identified M1, M2a, M2b, M2c, and M2d clusters at comparable frequencies between HC and RA synovial tissues. However, RA macrophage subsets exhibited a distinct proinflammatory shift, characterized by increased CD86 and VEGF expression, and reduced MerTK expression. In vitro , RA-derived macrophages displayed altered metabolic activity and a similar pathogenic phenotype, which was particularly pronounced in the M2c subset compared to HCs. Hypoxia significantly exacerbated these phenotypic discrepancies in RA M2c macrophages. Functional assays revealed that all macrophage subsets, except M2c, successfully differentiated into osteoclasts, with RA-derived cells yielding significantly higher numbers of pathogenic osteoclasts.
Conclusion: Dysregulated phenotypic, metabolic, and functional plasticity causes RA macrophages to adopt intermediate, pathogenic phenotypes. These alterations may impair tissue resolution, enhance osteoclastogenesis, and sustain chronic inflammation in the arthritic joint.
Related
- Macrophage functional plasticity in periodontitis: microenvironmental regulation, disease progression, and therapeutic targeting
- VIRMA-associated SRD5A2 downregulation promotes BPH progression through ERα-CREB5-dependent epithelial plasticity
- Vascular Smooth Muscle Cell Plasticity in Atherosclerosis: From Macrophage-like Transdifferentiation to Therapeutic Targeting
- PPARγ brakes cytosolic DNA-induced macrophage inflammation by super-enhancer metabolic reprogramming
- Alternatively polarized neutrophils metabolically restrain macrophage-driven inflammation
BibTeX
@article{kulakova2026defective,
title = {{Defective macrophage plasticity exacerbates progression of inflammation in patients with rheumatoid arthritis}},
author = {Karina Kulakova and Daphni Doulaptsi Teeuwen and Roozbeh Sanaei and Eoghan McCarthy and Laura Durcan and Cathrine Hughes and Colm Kirby and Michael Freeley and Achilleas Floudas},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1869466},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1869466/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Defective macrophage plasticity exacerbates progression of inflammation in patients with rheumatoid arthritis
AU - Karina Kulakova
AU - Daphni Doulaptsi Teeuwen
AU - Roozbeh Sanaei
AU - Eoghan McCarthy
AU - Laura Durcan
AU - Cathrine Hughes
AU - Colm Kirby
AU - Michael Freeley
AU - Achilleas Floudas
PY - 2026
DA - 2026/10/28
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1869466
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1869466/full
AB - Background: Rheumatoid arthritis (RA) affects over 1% of the global population. Current therapies cannot cure the disease, and only 20% of patients achieve long-term, drug-free remission. Recent studies highlight a dual role for synovial macrophages, which comprise both proinflammatory and remission-associated subsets. However, how macrophage plasticity and metabolic programming drive RA pathogenesis remains poorly understood. This study investigated how phenotypic and functional shifts in macrophage subsets contribute to chronic joint inflammation and bone erosion. Methods: Peripheral blood CD14+ monocytes from RA patients and healthy controls (HC) were differentiated into M1, M2a, M2b, M2c, and M2d macrophage subsets. To simulate the inflamed joint, cells were cultured under both atmospheric oxygen and hypoxic conditions. Phenotypic and chemokine receptor profiles were evaluated using RT-qPCR and multiparametric flow cytometry for a panel of markers, including CD14, CD11c, CD38, CD86, CD163, CD206, CD209, MerTK, IRF4, CCR1, CCR2, CCR4, CCR5, and CCR8. Metabolic characterization was performed via flow cytometric assessment of protein synthesis. To validate these phenotypes in vivo , scRNA-seq analysis (GSE200815) was conducted on synovial tissue macrophages from RA and HC individuals. Finally, the functional capacity of each macrophage subtype to differentiate into bone-resorbing osteoclasts was assessed. Results: scRNA-seq data identified M1, M2a, M2b, M2c, and M2d clusters at comparable frequencies between HC and RA synovial tissues. However, RA macrophage subsets exhibited a distinct proinflammatory shift, characterized by increased CD86 and VEGF expression, and reduced MerTK expression. In vitro , RA-derived macrophages displayed altered metabolic activity and a similar pathogenic phenotype, which was particularly pronounced in the M2c subset compared to HCs. Hypoxia significantly exacerbated these phenotypic discrepancies in RA M2c macrophages. Functional assays revealed that all macrophage subsets, except M2c, successfully differentiated into osteoclasts, with RA-derived cells yielding significantly higher numbers of pathogenic osteoclasts. Conclusion: Dysregulated phenotypic, metabolic, and functional plasticity causes RA macrophages to adopt intermediate, pathogenic phenotypes. These alterations may impair tissue resolution, enhance osteoclastogenesis, and sustain chronic inflammation in the arthritic joint.
SN - 1664-3224
ER -